GlassScriptPhysician profile
Katrina Korreckt
NPI 1124503974
$1,097.60
in general payments reported to CMS, 2019-2025
11 companies · $589 in 2025
The $589 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.49 · 2023: $203 · 2024: $208 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $288.49 | 2023-2025 | Triclip, Mitraclip, Navitor |
| Edwards Lifesciences Corporation | $226.58 | 2022-2025 | Evoque |
| Astrazeneca Pharmaceuticals LP | $151.00 | 2022-2025 | Farxiga |
| Pfizer INC. | $134.76 | 2024-2025 | |
| Medtronic, INC. | $97.68 | 2022-2024 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $63.10 | 2022-2024 | Xarelto |
| Bridgebio Pharma, INC. | $34.86 | 2025 | Attruby |
| Novo Nordisk INC | $33.68 | 2025 | Wegovy |
| Abiomed | $27.87 | 2025 | |
| Boston Scientific Corporation | $26.35 | 2023 | Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.23 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Korreckt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.